Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejection

Carlos E. Bacchi, Christopher L. Marsh, James D. Perkins, Robert L. Carithers, John McVicar, Kelly L. Hudkins, Christopher D. Benjamin, John M. Harlan, Roy Lobb, Charles E. Alpers

Research output: Contribution to journalArticle

51 Scopus citations

Abstract

VCAM-1, a leukocyte adhesion molecule expressed by cytokine-activated endothelial cells in culture, may mediate mononuclear leukocyte infiltration in vessels and interstitium in solid organ allograft rejection. Using the avidin-biotin immunoperoxidase technique and two different antibodies - 4B9, a murine monoclonal antibody, and rabbit polyclonal antisera to recombinant human VCAM (rVCAM Ab), which work in methacarn-flxed tissues - we studied the expression of this molecule in biopsies of transplanted liver and pancreas with and without features of rejection as well as nontransplant control tissues. The rVCAM Ab, but not 4B9, showed a population of reactive endothelial cells limited to sites of prominent subendothelial leukocytic cell infiltration in arteries and veins in rejecting allografts. VCAM-1 expression by sinusoidal endothelium in rejecting liver allografts was also observed. In addition, a population of cells (DC) with dendritic morphology was identified by rVCAM Ab within sites of lymphoid cell aggregations in both liver and pancreas allografts. Further evidence that these cells represent true DC was obtained by identification of VCAM-1 positive morphologically similar cells in both germinal centers and interfollicular areas of reactive lymph nodes; and by similar staining of these cells in allograft organs by a monoclonal antibody to nerve growth factor receptor, previously shown to recognize DC, DCs were generally not seen in normal control organs or portions of allografts uninvolved by lymphoid aggregates. This study provides evidence that 1) endothelial cell expression of VCAM-1 may be important in transplant rejection, 2) different epitopes of VCAM-1 may be preserved in tissue sections and recognized by different antibodies, and 3) there is probably a population of VCAM-1 expressing DC that participates in the cellular rejection progress.

Original languageEnglish (US)
Pages (from-to)579-591
Number of pages13
JournalAmerican Journal of Pathology
Volume142
Issue number2
StatePublished - Feb 1993
Externally publishedYes

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejection'. Together they form a unique fingerprint.

  • Cite this

    Bacchi, C. E., Marsh, C. L., Perkins, J. D., Carithers, R. L., McVicar, J., Hudkins, K. L., Benjamin, C. D., Harlan, J. M., Lobb, R., & Alpers, C. E. (1993). Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejection. American Journal of Pathology, 142(2), 579-591.